Boothbay Fund Management’s Kyntra Bio KYNB Stock Holding History

Boothbay Fund Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,052	Closed	-$206K	–	1843
2023 Q2	$206K	Buy	+3,052	New	+$1.26M	﹤0.01%	1480
2021 Q3	–	Sell	-872	Closed	-$581K	–	1985
2021 Q2	$581K	Buy	872 +858	+6,129%	+$494K	0.02%	933
2021 Q1	$1.22M	Buy	14 +3	+27%	+$3.19K	0.05%	506
2020 Q4	$1M	Buy	11 +2	+22%	+$2.1K	0.04%	489
2020 Q3	$905K	Buy	9 +5	+125%	+$5.38K	0.05%	467
2020 Q2	$377K	Hold	4	–	–	0.03%	642
2020 Q1	$323K	Buy	+4	New	+$3.98K	0.03%	553
2019 Q4	–	Sell	-4	Closed	-$392K	–	881
2019 Q3	$392K	Hold	4	–	–	0.04%	516
2019 Q2	$479K	Sell	4 -5	-56%	-$5.47K	0.04%	423
2019 Q1	$1.21M	Buy	9 +6	+200%	+$8.14K	0.12%	197
2018 Q4	$393K	Buy	+3	New	+$3.37K	0.06%	327

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boothbay Fund Management's KYNB Position: Q3 2023 in Review

Boothbay Fund Management sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 1,526 shares — an estimated $103K sold.

Boothbay Fund Management first reported a position in KYNB in Q2 2023 and held it in 1 quarter. The position peaked at $103K in Q2 2023. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

Boothbay Fund Management reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
Boothbay Fund Management sold 1,526 Kyntra Bio shares in Q3 2023, an estimated $103K.
Boothbay Fund Management first reported a position in Kyntra Bio in Q2 2023 and held it in 1 quarter.
Boothbay Fund Management's Kyntra Bio position peaked at $103K in Q2 2023.
110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.